TP53 and neoplasm: We also compared the TP53 mutations to the VIM methylation in the TCGA dataset and overall, the HCC tumors harboring TP53 mutation seemed to have lower levels of VIM methylation than the tumors with wild type TP53, especially in the earlier tumor stages.